Zenpep

BRIDGEWATER, NJ -- (MARKET WIRE) -- 07/14/11 -- Aptalis Pharma, a global specialty pharmaceutical company focused on gastrointestinal diseases and cystic fibrosis (CF), today announced that the U.S. Food and Drug Administration (FDA) has approved a new strength of ZENPEP (pancrelipase) Delayed-Release Capsules.